Klein Lawrence Otto
Insider CIK 1762583 · CRSP Chief Business Officer · JSPR Director · JBIO Director · DYN Director · ORKA Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-11-02 | 2026-11-02 | 25,000 | — | $0 | 1,503,513 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-11-02 | 2026-11-02 | 300 | $98.40 | $29.5K | 923,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-11-02 | 2026-11-02 | 756 | $97.45 | $73.7K | 923,428 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-11-02 | 2026-11-02 | 2,442 | $96.70 | $236.1K | 924,184 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-11-02 | 2026-11-02 | 15,036 | $95.64 | $1.44M | 926,626 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-11-02 | 2026-11-02 | 6,466 | $94.77 | $612.8K | 941,662 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-11-02 | 2026-11-02 | 25,000 | $7.80 | $195.0K | 948,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-02 | 25,000 | — | $0 | 1,528,513 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 200 | $84.78 | $17.0K | 923,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 8,554 | $84.03 | $718.8K | 923,328 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 16,246 | $83.40 | $1.35M | 931,882 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-10-01 | 2026-10-02 | 25,000 | $7.80 | $195.0K | 948,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 2,452 | $95.71 | $234.7K | 923,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 2,452 | $95.71 | $234.7K | 923,128 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-01 | 75,000 | — | $0 | 1,553,513 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 6,604 | $90.79 | $599.6K | 993,976 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-01 | 75,000 | $7.80 | $585.0K | 1,000,580 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 63,596 | $91.90 | $5.84M | 930,380 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 4,800 | $92.44 | $443.7K | 925,580 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-09-01 | 2026-09-01 | 75,000 | — | $0 | 1,553,513 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 4,800 | $92.44 | $443.7K | 925,580 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 63,596 | $91.90 | $5.84M | 930,380 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-01 | 6,604 | $90.79 | $599.6K | 993,976 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-09-01 | 2026-09-01 | 75,000 | $7.80 | $585.0K | 1,000,580 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-15 | 1,729 | $69.69 | $120.5K | 925,580 | SEC↗ |
| JBIO Jade Biosciences, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 34,843 | — | $0 | 34,843 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-03-16 | 2026-03-17 | 1,729 | $41.30 | $71.4K | 927,309 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-01-23 | 2026-01-23 | 306,700 | — | $0 | 306,700 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award | 2026-01-23 | 2026-01-23 | 76,700 | — | $0 | 929,038 | SEC↗ |
| JBIO Jade Biosciences, Inc. | A Award deriv | 2025-04-29 | 2025-05-01 | 23,017 | — | $0 | 23,017 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2025-01-22 | 2025-01-24 | 230,000 | — | $0 | 230,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 47,000 | — | $0 | 47,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award | 2022-10-12 | 2022-10-13 | 24,500 | — | $0 | 24,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-08-16 | 2022-08-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-07-05 | 2022-07-06 | 7,222 | — | $0 | 7,222 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-06-03 | 2022-06-06 | 19,596 | — | $0 | 19,596 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 78,045 | — | $0 | 78,045 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-03-14 | 2022-03-14 | 1,229 | $61.08 | $75.1K | 26,797 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-03-11 | 2022-03-14 | 3,000 | — | $0 | 9,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2022-03-11 | 2022-03-14 | 1,883 | $62.56 | $117.8K | 25,026 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-03-11 | 2022-03-14 | 3,000 | — | $0 | 28,026 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2022-03-10 | 2022-03-14 | 4,584 | — | $0 | 4,583 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2022-03-10 | 2022-03-14 | 4,584 | — | $0 | 26,909 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 20,400 | — | $0 | 20,400 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-02-18 | 2022-02-22 | 46,200 | — | $0 | 46,200 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-12-06 | 2021-12-07 | 11,185 | $69.17 | $773.7K | 22,325 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-12-03 | 2021-12-07 | 26,667 | — | $0 | 13,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-12-03 | 2021-12-07 | 26,667 | — | $0 | 33,510 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-10-15 | 2021-10-18 | 13,800 | — | $0 | 13,800 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-09-13 | 2021-09-14 | 4,207 | $117.86 | $495.8K | 6,843 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h deriv | 2021-09-10 | 2021-09-14 | 10,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-09-10 | 2021-09-14 | 10,000 | — | $0 | 11,050 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2021-05-26 | 2021-05-27 | 19,596 | — | $0 | 19,596 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 12,000 | — | $0 | 3,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 12,000 | — | $0 | 2,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 22,000 | — | $0 | 38,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 20,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-03-23 | 2021-03-25 | 12,000 | — | $0 | 43,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 12,000 | $17.66 | $211.9K | 101,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 12,000 | $44.67 | $536.0K | 25,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 22,000 | $51.49 | $1.13M | 47,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 10,000 | $29.87 | $298.7K | 57,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 20,000 | $40.87 | $817.4K | 77,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-03-23 | 2021-03-25 | 12,000 | $126.97 | $1.52M | 1,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-03-23 | 2021-03-25 | 88,000 | $128.20 | $11.28M | 13,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-23 | 2021-03-25 | 12,000 | $14.43 | $173.2K | 89,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 33,334 | — | $0 | 33,334 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-10 | 2021-03-12 | 4,583 | — | $0 | 15,191 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-10 | 2021-03-12 | 2,141 | $124.15 | $265.8K | 13,050 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-01-15 | 2021-01-20 | 16,334 | — | $0 | 14,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-01-15 | 2021-01-20 | 8,666 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 701 | $218.54 | $153.2K | 20,002 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 9,997 | $217.42 | $2.17M | 20,703 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,500 | $216.39 | $324.6K | 30,700 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 700 | $214.60 | $150.2K | 32,200 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 2,800 | $213.64 | $598.2K | 32,900 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 634 | $212.20 | $134.5K | 35,700 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-01-15 | 2021-01-20 | 16,344 | $14.43 | $235.8K | 36,334 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 2 | $219.99 | $440 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 400 | $216.24 | $86.5K | 20,200 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,400 | $214.46 | $300.2K | 20,600 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 1,200 | $213.71 | $256.5K | 22,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 2,555 | $212.54 | $543.0K | 23,200 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 2,911 | $211.44 | $615.5K | 25,755 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-01-15 | 2021-01-20 | 8,666 | $12.57 | $108.9K | 28,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-01-15 | 2021-01-20 | 200 | $217.45 | $43.5K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-01-15 | 2021-03-12 | 16,334 | $14.43 | $235.7K | 26,942 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-01-02 | 2021-01-04 | 9,392 | $153.11 | $1.44M | 10,608 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-10-05 | 2020-10-06 | 16,666 | — | $0 | 16,666 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 35,574 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 10,725 | — | $0 | 10,725 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy deriv | 2020-08-07 | 2020-09-23 | 35,574 | $2.81 | $100.0K | 35,574 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2020-07-31 | 2020-09-23 | 14,444 | — | $0 | 14,444 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2020-07-31 | 2020-09-23 | 11,156 | — | $0 | 11,156 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-06-25 | 2020-06-26 | 4,912 | — | $0 | 8,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-25 | 2020-06-26 | 4,912 | $75.18 | $369.3K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-06-25 | 2020-06-26 | 4,912 | $12.57 | $61.7K | 24,912 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-06-24 | 2020-06-26 | 26,422 | — | $0 | 13,578 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-06-24 | 2020-06-26 | 38,666 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 2,913 | $76.26 | $222.1K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-06-24 | 2020-06-26 | 26,422 | $12.57 | $332.1K | 46,422 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 22,700 | $76.50 | $1.74M | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 15,966 | $75.93 | $1.21M | 42,700 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-06-24 | 2020-06-26 | 38,666 | $5.86 | $226.6K | 58,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 12,175 | $75.32 | $917.0K | 22,913 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 800 | $76.50 | $61.2K | 35,088 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 3,934 | $75.94 | $298.7K | 35,888 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-24 | 2020-06-26 | 6,600 | $74.90 | $494.3K | 39,822 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-05-11 | 2020-05-13 | 25,000 | — | $0 | 38,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-11 | 2020-05-13 | 682 | $61.07 | $41.6K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-11 | 2020-05-13 | 24,318 | $60.38 | $1.47M | 20,682 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-05-11 | 2020-05-13 | 25,000 | $5.86 | $146.5K | 45,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 13,750 | — | $0 | 13,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-12-03 | 2019-12-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-09-10 | 2019-09-12 | 10,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-07-11 | 2019-07-12 | 8,421 | — | $0 | 63,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-07-11 | 2019-07-12 | 8,421 | $50.01 | $421.1K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-07-11 | 2019-07-12 | 8,421 | $5.86 | $49.3K | 28,421 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-07-10 | 2019-07-12 | 11,579 | — | $0 | 72,087 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-07-10 | 2019-07-12 | 11,579 | $5.86 | $67.9K | 31,579 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-07-10 | 2019-07-12 | 11,579 | $50.02 | $579.2K | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-03-05 | 2019-03-07 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-01-02 | 2019-01-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award | 2019-01-02 | 2019-01-03 | 20,000 | $29.87 | $597.4K | 20,000 | SEC↗ |